|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,540.00 ARS | -2.84% |
|
-1.91% | -22.03% |
| Market Cap | 12TCr 8.34Cr 7.3Cr 6.73Cr 6.24Cr 12Cr 795.32Cr 12Cr 81Cr 31Cr 390.39Cr 31Cr 31Cr 1.35TCr | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 36TCr 24Cr 21Cr 19Cr 18Cr 34Cr 2.27TCr 34Cr 230.08Cr 90Cr 1.12TCr 89Cr 88Cr 3.87TCr | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
| 1 day | -2.84% | ||
| 1 week | -1.91% | ||
| Current month | -1.91% | ||
| 1 month | -5.52% | ||
| 3 months | -8.88% | ||
| 6 months | -20.82% | ||
| Current year | -22.03% |
| 1 week | 1,520 | 1,615 | |
| 1 month | 1,520 | 1,670 | |
| Current year | 1,420 | 2,130 | |
| 1 year | 945 | 2,300 | |
| 3 years | 480.5 | 2,300 | |
| 5 years | 208.5 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Roberto Persico
BRD | Director/Board Member | - | - |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.84% | -1.91% | +12.41% | +205.56% | 8.34Cr | ||
| +3.02% | +3.40% | +60.47% | +174.35% | 1,07000Cr | ||
| +3.36% | +5.57% | +72.67% | +68.36% | 62TCr | ||
| +1.06% | +2.38% | +37.30% | +90.13% | 45TCr | ||
| +2.14% | -2.07% | +27.62% | +22.57% | 33TCr | ||
| +2.16% | +1.99% | +40.73% | +42.24% | 29TCr | ||
| +1.44% | +0.13% | +29.84% | +49.26% | 28TCr | ||
| +1.98% | +4.08% | -25.78% | -39.02% | 22TCr | ||
| +0.79% | +2.17% | +26.29% | +69.20% | 20TCr | ||
| +3.75% | +6.62% | +20.51% | +81.01% | 16TCr | ||
| Average | +1.73% | +0.69% | +30.21% | +76.36% | 36.24TCr | |
| Weighted average by Cap. | +2.45% | +0.70% | +43.93% | +88.79% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.18TCr 6.15Cr 5.39Cr 4.96Cr 4.61Cr 8.75Cr 587.06Cr 8.87Cr 59Cr 23Cr 288.17Cr 23Cr 23Cr 999.11Cr | 13TCr 8.5Cr 7.44Cr 6.85Cr 6.36Cr 12Cr 810.47Cr 12Cr 82Cr 32Cr 397.83Cr 32Cr 31Cr 1.38TCr |
| Net income | 2.38TCr 1.6Cr 1.4Cr 1.29Cr 1.2Cr 2.27Cr 152.5Cr 2.3Cr 15Cr 6.01Cr 75Cr 6Cr 5.87Cr 259.54Cr | 308.78Cr 20.7L 18.13L 16.7L 15.5L 29.44L 20Cr 29.84L 2Cr 77.8L 9.69Cr 77.75L 76.04L 34Cr |
| Net Debt | 13TCr 8.96Cr 7.85Cr 7.23Cr 6.71Cr 13Cr 854.73Cr 13Cr 87Cr 34Cr 419.55Cr 34Cr 33Cr 1.45TCr | 23TCr 15Cr 14Cr 12Cr 12Cr 22Cr 1.48TCr 22Cr 149.57Cr 58Cr 725.28Cr 58Cr 57Cr 2.51TCr |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | ARS 1,540.00 | -2.84% | 7,268 |
| 03/26/03 | ARS 1,585.00 | -0.31% | 3,541 |
| 02/26/02 | ARS 1,590.00 | +1.60% | 4,119 |
| 01/26/01 | ARS 1,565.00 | -0.32% | 2,683 |
| 30/26/30 | ARS 1,570.00 | 0.00% | 21,565 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions
















